Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001664281-25-000003

Director sold 200,000 shares at $8.80 ($1,760,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
PARMAR KUSH Director 2025-11-14 Sale −200,000 $8.80 $1,760,000 2,963,066 I
Open-market sales · 200,000 sh · avg $8.80 · $1,760,000
Loading xslF345X05/form4-11182025_091127.xml…